Immunotech Biopharm Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 6978?
Owner TypeNumber of SharesOwnership Percentage
Institutions623,0660.121%
General Public3,626,3440.705%
State or Government32,998,6196.41%
Private Companies51,458,40010%
Public Companies97,102,57118.9%
Individual Insiders328,775,00063.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 9 shareholders own 99.3% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
46.7%
Zheng Tan
240,274,286HK$740.0m0%no data
18.9%
Tasly Pharmaceutical Group Co., Ltd
97,102,571HK$299.1m0%no data
10%
China Resources Company Limited
51,458,400HK$158.5m0%no data
8.71%
Hyun Chul Jung
44,820,000HK$138.0m0%no data
8.1%
Junzheng Zhang
41,691,428HK$128.4m0%no data
6.41%
Greater Bay Area Development Fund
32,998,619HK$101.6m0%no data
0.39%
MinHui Wang
1,989,286HK$6.1m0%no data
0.12%
China Universal Asset Management Company Ltd.
622,000HK$1.9m0%no data
0.00021%
BMO Asset Management Corp.
1,066HK$3.3k0%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.